Dr Achal Srivasrtava

Dr. Achal Kumar Srivastava,
MBBS, MD, DM 
Professor, Department of Neurology,
Head, Unit III
Room #60, Ground Floor, Neurosciences Center, AIIMS , New Delhi 
Phone: +91 11 26546688 
Email:  This email address is being protected from spambots. You need JavaScript enabled to view it.
Outpatients clinic (General Neurology including Ataxia Clinic - Movement Disorder Clinic)

 Wednesday and Saturday (forenoon) 
For appointments: +91 11 26594656 or email to  This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Dr. Srivastava graduated from MLN Medical College, Allahabad, Uttar Pradesh in 1991 and completed his postgraduate degree (MD) in Medicine (1994) from the same college. Subsequently, he obtained post-doctoral specialist certification in DM (Neurology) in 1998 from the Department of Neurology, AIIMS, New Delhi. He worked as a Senior Scientist Grade Scientist Fellow for over a year at CSIR-Institute of Genomics and Integrative Biology (formerly known as Centre for Biochemical Technology) and then joined as Assistant Professor in the Department of Neurology in March 2001. He has a keen interest in teaching and has provided guidance and training to more than 120 DM and PhD students in their research work.

He is a Fellow of the Royal College of Physicians, London; the American Academy of Neurology, USA; the American Neurological Association, USA; the Indian Academy of Neurology, New Delhi; the National Academy of Medical Sciences, India; the National Academy of Sciences, India; and the Indian College of Physicians and Movement Disorders Society of India.

Currently, Dr. Achal Kumar Srivastava is Professor of Clinical Neurophysiology in the Department of Neurology at AIIMS, New Delhi, India. At AIIMS, he heads Unit-3, Department of Neurology; oversees the Clinical Neurophysiology Facility, Neurobiology Laboratory, Ataxia clinic and neurophysiotherapists and is a member of the Comprehensive Epilepsy care team at the CN Centre. He has special interest in ataxias, epilepsy and genetics of movement disorders. He serves on the AIIMS Ethics Subcommittee for SAEs in clinical trials and the Committee for addressing grievances of PhD students and faculty. He also served as an expert/member on DBT project monitoring and award-selection committees, DHR technical evaluation committee for medical research units, Board of Studies in Neurology at SGPGI Lucknow, Chancellor’s nominee for the University of Kashmir, and Ethics Committee of the Institute of Human Behaviour and Allied Sciences, New Delhi.

Dr. Srivastava has received academic awards at National and International scientific forums, mainly for his work in ataxias and the genetics of neurological disorders. He is a recipient of the A.B. Baker Teacher Recognition Award-2025 by American Academy of Neurology, USA; Kayastha Ratna Award by Akhil Bhartiya Kasyastha Mahashabha, New Delhi; Mati Samman by Mati NGO for Outstanding achievements in Neurology field; and Excellence in Neurology by Venus International Foundation, India for the exceptional practice and selfless dedication in Medical Super Specialty. The Molecular Biology Division at John Hopkins, USA, invited him to present his work on spinocerebellar ataxia type 12. He has received an outstanding paper presentation award from AINA at the American Academy of Neurology conference in San Francisco in 2004 and the best paper award at the Neurological Society of India conference in Hyderabad in 1998. He has received many travel fellowships to attend international conferences. He has received the Young Investigator Award for CAG triplet repeat disorder conferences in the USA and Italy. He has collaborative projects with many universities and research institutes. He is on the editorial board of the Journal of Clinical Neuroscience and many other journals of repute.

He has given prestigious Prof P Dhairyavan Oration, Dr. KL Wig Oration, Dr. KS Neogi Oration, and Dr. Shyama Narang Oration lectures. He has received more than 40 paper presentation awards and has more than 430 publications, with an h–index of 41 (Full list of publications: https://pubmed.ncbi.nlm.nih.gov/?term=srivastava+achal).

Selected publications:

1. Swarup V, Deepika D, Garg D, Srivastava AK. Translational Paradox of Triplet Repeat Expansion Disorders: Synthesizing Clinical Trial Failures to Guide Future Therapeutics.Clinical Pharmacology & Therapeutics. Accepted for publication: 04^thAugust, 2026.

2. Yadav RK, Swarup V, Ahuja A, Talukdar D, Garg D, Aski M, Srivastava AK, Yadav P. Genetic modifiers of Friedreich's ataxia pathophysiology in Drosophila melanogaster - A systematic review and meta-analysis. Free Radic Biol Med. 2026 Jun 16;254:196-210.

3. Rossi M, Stephen CD, Damásio J, Pedroso JL, Kuo SH, Lin CR, Ojo O, El-Jaafary S, Lee WW, Madoev H, Barsottini OGP, Srivastava AK, Klein C, van de Warrenburg BP. Unravelling the Global Tapestry of Genetic Ataxias: Epidemiology and Genetic Testing Approaches. Mov Disord. 2025 Sep;40(9):1805-1820.

4. De T, Sharma P, Upilli B, Vivekanand A, Bari S, Sonakar AK, Srivastava AK, Faruq M. Spinocerebellar ataxia type 27B (SCA27B) in India: insights from a large cohort study suggest ancient origin. Neurogenetics. 2024 Oct;25(4):393-403.

5. Kumar M, Sahni S, A V, Kumar D, Kushwah N, Goel D, Kapoor H, Srivastava AK, Faruq M. Molecular clues unveiling spinocerebellar ataxia type-12 pathogenesis. iScience. 2024 Apr 18;27(5):109768.

6. Uppili B, Sharma P, Ahmad I, Sahni S, Asokachandran V, Nagaraja AB, Srivastava AK, Faruq M. Sequencing through hyperexpanded Friedreich's ataxia-GAA repeats by nanopore technology: implications in genotype-phenotype correlation. Brain Commun. 2023 Mar 29;5(2):fcad020.  

7. Sharma P, Sonakar AK, Goel V, Garg A, Srivastava AK, Faruq M. A Novel Co-existence of Spinocerebellar Ataxia 1 and Spinocerebellar Ataxia 2 Mutations in Indian Patients. Mov Disord Clin Pract. 2022 May 10;9(5):688-692. doi: 10.1002/mdc3.13464. PMID: 35844270; PMCID: PMC9274345.

8. Puri I, Garg D, Srivastava AK, Singh L, Shukla G, Goyal V. Langerhans Cell Histiocytosis Presenting With Late-Onset Sporadic Ataxia. Mov Disord Clin Pract. 2019 Sep 18;6(8):716-718.

9. Srivastava AK, Takkar A, Garg A, Faruq M. Clinical behaviour of spinocerebellar ataxia type 12 and intermediate length abnormal CAG repeats in PPP2R2B. Brain. 2017 Jan;140(Pt 1):27-36.

10. Erwin GS, Grieshop MP, Ali A, Qi J, Lawlor M, Kumar D, Ahmad I, McNally A, Teider N, Worringer K, Sivasankaran R, Syed DN, Eguchi A, Ashraf M, Jeffery J, Xu M, Park PMC, Mukhtar H, Srivastava AK, Faruq M, Bradner JE, Ansari AZ.  Synthetic  transcription elongation factors license transcription across repressive chromatin. Science, 2017. Nov 30. pii: eaan6414. doi: 10.1126/science.aan6414.

11. Swarup V, Srivastava AK, Padma MV, Rajeswari MR. Quantitative profiling and identification of differentially expressed plasma proteins in Friedreich's ataxia. J Neurosci Res. 2013 Nov;91(11):1483-91

12. Swarup V, Srivastava AK, Padma MV, Moganty RR. Quantitative Profiling and Identification of Plasma Proteins of Spinocerebellar Ataxia Type 2 Patients. Neurodegenerative Diseases. 2013, 12(4):199-206.

13. Singh I, Faruq M, Mukherjee O, Jain S, Pal PK, Srivastav MV, Behari M, Srivastava AK, Mukerji M. North and South Indian populations share a common ancestral origin of Friedreich's ataxia but vary in age of GAA repeat expansion. Ann Hum Genet. 2010 May;74(3):202-10.

14. Mittal U, Srivastava AK, Jain Satish, Jain Sanjeev, Mukerji M. Founder haplotype for Machado-Joseph disease in the Indian population: novel insights from history and polymorphism studies. Arch Neurol. 2005 Apr; 62(4):637-640.

15. Srivastava AK, Choudhry S, Gopinath MS, Tripathi M, Brahmachari SK, Jain S. Molecular and clinical correlation in five Indian families with Spinocerebellar ataxia 12. Annals of Neurology 2001; 50:796-800